Showing 1,461 - 1,480 results of 2,039 for search '"Rheumatology"', query time: 0.05s Refine Results
  1. 1461

    Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published 2024-10-01
    “…Results Overall, 911 patients were included: 507 from rheumatology centres [116 with rheumatoid arthritis (RA), 78 psoriatic arthritis (PsA), and 313 ankylosing spondylitis (AS)] and 404 from gastroenterology centres [316 with Crohn’s disease (CD) and 88 ulcerative colitis (UC)]. …”
    Get full text
    Article
  2. 1462

    Arteritis de células gigantes: actualización diagnóstica y terapéutica by Paloma Muñoz-Reinoso, Ana Domínguez-Mayoral, Francisco J. Toyos-Sáenz de Miera, Laura Castillo-Moreno, Sara Banda-Ramírez, José J. Pérez-Venegas

    Published 2024-10-01
    “…Se han tomado como referencia los protocolos diagnósticos y terapéuticos elaborados por el American College of Rheumatology y la European Alliance of Associations for Rheumatology. …”
    Get full text
    Article
  3. 1463
  4. 1464
  5. 1465
  6. 1466
  7. 1467
  8. 1468

    RISK FACTORS OF LIFE QUALITY REDUCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS by Vitalii Dubas

    Published 2022-12-01
    “…Abbreviations: ACR - American College of Rheumatology AIDS - acquired immunodeficiency syndrome ANFH - avascular necrosis of femoral head CF - Cyclophosphamide EULAR - The European Alliance of Associations for Rheumatology GC - glucocorticoids MMF - Mycophenolate mofetil SLE - systemic lupus erythematosus SLICC - The Systemic Lupus Erythematosus International Collaborating Clinics QoL - Quality of life…”
    Get full text
    Article
  9. 1469
  10. 1470
  11. 1471
  12. 1472
  13. 1473
  14. 1474
  15. 1475
  16. 1476

    Role of Huangqin Qingre Chubi Capsule in the Reduction of the Risk of Re-Admission in Patients With Ankylosing Spondylitis: A Cohort Study by Qi Y, Liu J, Chen Y, Hu Y, Zhou Q, Huang D, Cong C, Li Y

    Published 2025-01-01
    “…Yajun Qi,1– 3 Jian Liu,1,3 Yiming Chen,1,3 Yuedi Hu,1,3 Qiao Zhou,1,3 Dan Huang,1,3 Chengzhi Cong,1,3 Yang Li1,3 1The First College of Clinical Medicine, Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China; 2College of Acupuncture and Massage, Anhui University of Chinese Medicine, Hefei, Anhui Province, 230012, People’s Republic of China; 3Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of ChinaCorrespondence: Jian Liu, Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People’s Republic of China, Email liujianahzy@126.comObjective: This study evaluates whether Huangqin Qingre Chubi Capsule (HQC), a traditional Chinese medicine (TCM) compound, is associated with the risk of re-admission in patients with ankylosing spondylitis (AS).Methods: In this study, we retrospectively collected the clinical data of 1,296 AS patients. …”
    Get full text
    Article
  17. 1477
  18. 1478
  19. 1479
  20. 1480